在无症状的克鲁茨菲尔特-雅各布病中重新配置的新陈代谢大脑网络

Yu Kong1, Zhongyun Chen2, Jing Zhang2

  • 1Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China; Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

Neurobiology of disease
|January 15, 2025
PubMed
概括

大脑代谢网络的变化发生在PRNP G114V突变的无症状载体中,在克鲁茨菲尔特-雅各布病 (CJD) 的临床症状之前. 大脑连接的这些拓变化可能作为遗传CJD的早期诊断生物标志物.

相关概念视频

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...